Table 1.
Multivariable Cox Regression Analysis for Posttransplant Mortality in the 675 Propensity‐Matched Patients
| Covariate | Hazard Ratio | 95% CI | P Value |
|---|---|---|---|
| Hepatitis C–positive donor | 1.05 | 0.70–1.58 | 0.80 |
| Donor age (increasing, per year) | 1.01 | 1.01–1.02 | <0.001 |
| Recipient age (increasing, per year) | 1.02 | 1.01–1.02 | <0.001 |
| Etiology of heart failure | |||
| Nonischemic dilated cardiomyopathy | Reference | Reference | Ref. |
| Ischemic cardiomyopathy | 1.12 | 0.95–1.32 | 0.17 |
| Congenital heart disease | 2.36 | 1.59–3.51 | <0.001 |
| Restrictive cardiomyopathy | 1.60 | 1.15–2.24 | 0.006 |
| Valvular heart disease | 0.90 | 0.44–1.86 | 0.78 |
| Failed primary heart transplant | 1.93 | 1.26–2.97 | 0.003 |
| Hypertrophic cardiomyopathy | 0.89 | 0.53–1.49 | 0.65 |
| Other etiology | 0.83 | 0.47–1.48 | 0.53 |
| Diabetes mellitus | 1.22 | 1.05–1.43 | 0.01 |
| Serum creatinine (increasing, per 1 mg/dL) | 1.05 | 1.00–1.11 | 0.07 |
| Serum bilirubin (increasing, per 1 g/dL) | 1.08 | 1.06–1.10 | <0.001 |
| Mechanical ventilation | 1.83 | 1.05–3.20 | 0.03 |
| Bridge with ECMO | 2.74 | 1.59–4.72 | <0.001 |
| Bridge with ventricular assist device | |||
| None | Reference | Reference | Ref. |
| Left ventricular assist device | 1.21 | 1.04–1.42 | 0.01 |
| Right ventricular assist device | 5.53 | 2.25–13.6 | <0.001 |
| Biventricular assist device | 3.62 | 2.27–5.76 | <0.001 |
ECMO indicates extracorporeal membrane oxygenation.